nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C9—brain cancer	0.753	1	CbGaD
Formoterol—CYP2D6—Lomustine—brain cancer	0.0687	0.569	CbGbCtD
Formoterol—CYP2D6—Hydroxyurea—brain cancer	0.0521	0.431	CbGbCtD
Formoterol—Cerebral infarction—Carmustine—brain cancer	0.00249	0.0218	CcSEcCtD
Formoterol—Neoplasm—Lomustine—brain cancer	0.00185	0.0162	CcSEcCtD
Formoterol—Metabolic acidosis—Etoposide—brain cancer	0.00159	0.0139	CcSEcCtD
Formoterol—Dysphonia—Procarbazine—brain cancer	0.00158	0.0138	CcSEcCtD
Formoterol—Arformoterol—CYP2C9—brain cancer	0.00155	1	CrCbGaD
Formoterol—Nocturia—Procarbazine—brain cancer	0.0014	0.0123	CcSEcCtD
Formoterol—Oral candidiasis—Carmustine—brain cancer	0.00128	0.0112	CcSEcCtD
Formoterol—Melaena—Procarbazine—brain cancer	0.00127	0.0111	CcSEcCtD
Formoterol—Oral candidiasis—Temozolomide—brain cancer	0.00123	0.0108	CcSEcCtD
Formoterol—Hypokinesia—Carmustine—brain cancer	0.0012	0.0105	CcSEcCtD
Formoterol—Lung disorder—Temozolomide—brain cancer	0.00111	0.00972	CcSEcCtD
Formoterol—Herpes zoster—Temozolomide—brain cancer	0.00104	0.00913	CcSEcCtD
Formoterol—Abscess—Carmustine—brain cancer	0.00103	0.00899	CcSEcCtD
Formoterol—Injection site pain—Carmustine—brain cancer	0.000993	0.00872	CcSEcCtD
Formoterol—Visual impairment—Lomustine—brain cancer	0.000988	0.00867	CcSEcCtD
Formoterol—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.000927	0.0852	CbGpPWpGaD
Formoterol—Neoplasm—Hydroxyurea—brain cancer	0.000907	0.00796	CcSEcCtD
Formoterol—Viral infection—Temozolomide—brain cancer	0.000868	0.00761	CcSEcCtD
Formoterol—Leukocytosis—Carmustine—brain cancer	0.000863	0.00757	CcSEcCtD
Formoterol—Herpes simplex—Temozolomide—brain cancer	0.000851	0.00746	CcSEcCtD
Formoterol—Infection—Carboplatin—brain cancer	0.000827	0.00726	CcSEcCtD
Formoterol—Angina pectoris—Procarbazine—brain cancer	0.000792	0.00695	CcSEcCtD
Formoterol—Candida infection—Carmustine—brain cancer	0.000774	0.00679	CcSEcCtD
Formoterol—Candida infection—Temozolomide—brain cancer	0.000748	0.00657	CcSEcCtD
Formoterol—Neoplasm—Carmustine—brain cancer	0.000733	0.00643	CcSEcCtD
Formoterol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00073	0.067	CbGpPWpGaD
Formoterol—Infection—Lomustine—brain cancer	0.000724	0.00635	CcSEcCtD
Formoterol—Pain—Carboplatin—brain cancer	0.000712	0.00625	CcSEcCtD
Formoterol—Neoplasm—Temozolomide—brain cancer	0.000709	0.00622	CcSEcCtD
Formoterol—Abnormal vision—Carmustine—brain cancer	0.000707	0.00621	CcSEcCtD
Formoterol—Skin discolouration—Etoposide—brain cancer	0.000694	0.00609	CcSEcCtD
Formoterol—Haematuria—Procarbazine—brain cancer	0.000691	0.00607	CcSEcCtD
Formoterol—Abnormal vision—Temozolomide—brain cancer	0.000684	0.006	CcSEcCtD
Formoterol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000664	0.061	CbGpPWpGaD
Formoterol—Body temperature increased—Carboplatin—brain cancer	0.000658	0.00578	CcSEcCtD
Formoterol—Inflammation—Etoposide—brain cancer	0.000647	0.00567	CcSEcCtD
Formoterol—Gastroenteritis—Temozolomide—brain cancer	0.000642	0.00563	CcSEcCtD
Formoterol—Injury—Carmustine—brain cancer	0.000641	0.00562	CcSEcCtD
Formoterol—Nasal congestion—Temozolomide—brain cancer	0.000625	0.00548	CcSEcCtD
Formoterol—Candida infection—Etoposide—brain cancer	0.000599	0.00525	CcSEcCtD
Formoterol—Arrhythmia—Procarbazine—brain cancer	0.000582	0.0051	CcSEcCtD
Formoterol—Body temperature increased—Lomustine—brain cancer	0.000576	0.00505	CcSEcCtD
Formoterol—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000575	0.0528	CbGpPWpGaD
Formoterol—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000565	0.052	CbGpPWpGaD
Formoterol—Tension—Procarbazine—brain cancer	0.000556	0.00488	CcSEcCtD
Formoterol—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000553	0.0508	CbGpPWpGaD
Formoterol—Nervousness—Procarbazine—brain cancer	0.00055	0.00483	CcSEcCtD
Formoterol—Hypokalaemia—Carmustine—brain cancer	0.000536	0.0047	CcSEcCtD
Formoterol—Tremor—Procarbazine—brain cancer	0.000531	0.00466	CcSEcCtD
Formoterol—Dehydration—Temozolomide—brain cancer	0.000529	0.00464	CcSEcCtD
Formoterol—Dry skin—Temozolomide—brain cancer	0.000522	0.00458	CcSEcCtD
Formoterol—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00052	0.0478	CbGpPWpGaD
Formoterol—Hypokalaemia—Temozolomide—brain cancer	0.000518	0.00454	CcSEcCtD
Formoterol—Cardiac failure congestive—Etoposide—brain cancer	0.000502	0.00441	CcSEcCtD
Formoterol—Cough—Procarbazine—brain cancer	0.000495	0.00434	CcSEcCtD
Formoterol—Hypertension—Procarbazine—brain cancer	0.000489	0.00429	CcSEcCtD
Formoterol—Arthralgia—Procarbazine—brain cancer	0.000482	0.00423	CcSEcCtD
Formoterol—Myalgia—Procarbazine—brain cancer	0.000482	0.00423	CcSEcCtD
Formoterol—Anxiety—Procarbazine—brain cancer	0.000481	0.00422	CcSEcCtD
Formoterol—Bronchitis—Temozolomide—brain cancer	0.000473	0.00415	CcSEcCtD
Formoterol—Dry mouth—Procarbazine—brain cancer	0.000472	0.00414	CcSEcCtD
Formoterol—Vomiting—Lomustine—brain cancer	0.000463	0.00406	CcSEcCtD
Formoterol—Oedema—Procarbazine—brain cancer	0.000463	0.00406	CcSEcCtD
Formoterol—Infection—Procarbazine—brain cancer	0.00046	0.00403	CcSEcCtD
Formoterol—Hyperglycaemia—Carmustine—brain cancer	0.000459	0.00403	CcSEcCtD
Formoterol—Upper respiratory tract infection—Temozolomide—brain cancer	0.000457	0.00401	CcSEcCtD
Formoterol—Tachycardia—Procarbazine—brain cancer	0.000451	0.00396	CcSEcCtD
Formoterol—Hyperglycaemia—Temozolomide—brain cancer	0.000444	0.00389	CcSEcCtD
Formoterol—Urinary tract infection—Carmustine—brain cancer	0.000441	0.00387	CcSEcCtD
Formoterol—Nausea—Lomustine—brain cancer	0.000433	0.0038	CcSEcCtD
Formoterol—Hypotension—Procarbazine—brain cancer	0.000432	0.00379	CcSEcCtD
Formoterol—Urinary tract infection—Temozolomide—brain cancer	0.000426	0.00374	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000421	0.0037	CcSEcCtD
Formoterol—Insomnia—Procarbazine—brain cancer	0.000418	0.00367	CcSEcCtD
Formoterol—Sinusitis—Temozolomide—brain cancer	0.000411	0.00361	CcSEcCtD
Formoterol—Somnolence—Procarbazine—brain cancer	0.000411	0.00361	CcSEcCtD
Formoterol—Cramp muscle—Etoposide—brain cancer	0.00041	0.0036	CcSEcCtD
Formoterol—Ill-defined disorder—Hydroxyurea—brain cancer	0.000407	0.00357	CcSEcCtD
Formoterol—Oedema peripheral—Carmustine—brain cancer	0.000401	0.00352	CcSEcCtD
Formoterol—Connective tissue disorder—Carmustine—brain cancer	0.0004	0.00351	CcSEcCtD
Formoterol—Fatigue—Procarbazine—brain cancer	0.000399	0.0035	CcSEcCtD
Formoterol—Malaise—Hydroxyurea—brain cancer	0.000396	0.00347	CcSEcCtD
Formoterol—Pain—Procarbazine—brain cancer	0.000396	0.00347	CcSEcCtD
Formoterol—Constipation—Procarbazine—brain cancer	0.000396	0.00347	CcSEcCtD
Formoterol—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000395	0.0363	CbGpPWpGaD
Formoterol—Visual impairment—Carmustine—brain cancer	0.000393	0.00344	CcSEcCtD
Formoterol—Pharyngitis—Temozolomide—brain cancer	0.000391	0.00343	CcSEcCtD
Formoterol—Urinary tract disorder—Temozolomide—brain cancer	0.000389	0.00341	CcSEcCtD
Formoterol—Oedema peripheral—Temozolomide—brain cancer	0.000388	0.0034	CcSEcCtD
Formoterol—Bronchospasm—Etoposide—brain cancer	0.000387	0.0034	CcSEcCtD
Formoterol—Connective tissue disorder—Temozolomide—brain cancer	0.000387	0.00339	CcSEcCtD
Formoterol—Urethral disorder—Temozolomide—brain cancer	0.000386	0.00339	CcSEcCtD
Formoterol—Feeling abnormal—Procarbazine—brain cancer	0.000381	0.00334	CcSEcCtD
Formoterol—Visual impairment—Temozolomide—brain cancer	0.000379	0.00333	CcSEcCtD
Formoterol—Gastrointestinal pain—Procarbazine—brain cancer	0.000378	0.00332	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000371	0.00325	CcSEcCtD
Formoterol—Discomfort—Hydroxyurea—brain cancer	0.000369	0.00324	CcSEcCtD
Formoterol—Urticaria—Procarbazine—brain cancer	0.000367	0.00322	CcSEcCtD
Formoterol—Abdominal pain—Procarbazine—brain cancer	0.000366	0.00321	CcSEcCtD
Formoterol—Body temperature increased—Procarbazine—brain cancer	0.000366	0.00321	CcSEcCtD
Formoterol—Cardiac disorder—Temozolomide—brain cancer	0.000365	0.00321	CcSEcCtD
Formoterol—Arrhythmia—Carmustine—brain cancer	0.000364	0.00319	CcSEcCtD
Formoterol—Oedema—Hydroxyurea—brain cancer	0.000358	0.00314	CcSEcCtD
Formoterol—Mental disorder—Carmustine—brain cancer	0.000357	0.00313	CcSEcCtD
Formoterol—Infection—Hydroxyurea—brain cancer	0.000356	0.00312	CcSEcCtD
Formoterol—Immune system disorder—Temozolomide—brain cancer	0.000356	0.00312	CcSEcCtD
Formoterol—Mediastinal disorder—Temozolomide—brain cancer	0.000355	0.00311	CcSEcCtD
Formoterol—Malnutrition—Carmustine—brain cancer	0.000355	0.00311	CcSEcCtD
Formoterol—Nervous system disorder—Hydroxyurea—brain cancer	0.000351	0.00308	CcSEcCtD
Formoterol—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000351	0.0322	CbGpPWpGaD
Formoterol—Skin disorder—Hydroxyurea—brain cancer	0.000348	0.00305	CcSEcCtD
Formoterol—Acute coronary syndrome—Etoposide—brain cancer	0.000346	0.00303	CcSEcCtD
Formoterol—Mental disorder—Temozolomide—brain cancer	0.000345	0.00303	CcSEcCtD
Formoterol—Myocardial infarction—Etoposide—brain cancer	0.000344	0.00302	CcSEcCtD
Formoterol—Back pain—Carmustine—brain cancer	0.000343	0.00301	CcSEcCtD
Formoterol—Malnutrition—Temozolomide—brain cancer	0.000343	0.00301	CcSEcCtD
Formoterol—Hypersensitivity—Procarbazine—brain cancer	0.000341	0.00299	CcSEcCtD
Formoterol—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000337	0.031	CbGpPWpGaD
Formoterol—Dysgeusia—Temozolomide—brain cancer	0.000336	0.00294	CcSEcCtD
Formoterol—Tremor—Carmustine—brain cancer	0.000332	0.00291	CcSEcCtD
Formoterol—Asthenia—Procarbazine—brain cancer	0.000332	0.00291	CcSEcCtD
Formoterol—Back pain—Temozolomide—brain cancer	0.000331	0.00291	CcSEcCtD
Formoterol—Pruritus—Procarbazine—brain cancer	0.000327	0.00287	CcSEcCtD
Formoterol—Agitation—Carmustine—brain cancer	0.000326	0.00286	CcSEcCtD
Formoterol—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000322	0.0296	CbGpPWpGaD
Formoterol—Tremor—Temozolomide—brain cancer	0.000321	0.00282	CcSEcCtD
Formoterol—Dyspnoea—Hydroxyurea—brain cancer	0.000319	0.0028	CcSEcCtD
Formoterol—Somnolence—Hydroxyurea—brain cancer	0.000318	0.00279	CcSEcCtD
Formoterol—Ill-defined disorder—Temozolomide—brain cancer	0.000318	0.00279	CcSEcCtD
Formoterol—Diarrhoea—Procarbazine—brain cancer	0.000316	0.00278	CcSEcCtD
Formoterol—Dyspepsia—Hydroxyurea—brain cancer	0.000315	0.00276	CcSEcCtD
Formoterol—Agitation—Temozolomide—brain cancer	0.000315	0.00276	CcSEcCtD
Formoterol—Angioedema—Temozolomide—brain cancer	0.000313	0.00275	CcSEcCtD
Formoterol—Urinary tract disorder—Etoposide—brain cancer	0.000311	0.00273	CcSEcCtD
Formoterol—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00031	0.0285	CbGpPWpGaD
Formoterol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000309	0.00271	CcSEcCtD
Formoterol—Malaise—Temozolomide—brain cancer	0.000309	0.00271	CcSEcCtD
Formoterol—Urethral disorder—Etoposide—brain cancer	0.000309	0.00271	CcSEcCtD
Formoterol—Fatigue—Hydroxyurea—brain cancer	0.000309	0.00271	CcSEcCtD
Formoterol—Hypertension—Carmustine—brain cancer	0.000306	0.00269	CcSEcCtD
Formoterol—Pain—Hydroxyurea—brain cancer	0.000306	0.00269	CcSEcCtD
Formoterol—Constipation—Hydroxyurea—brain cancer	0.000306	0.00269	CcSEcCtD
Formoterol—Dizziness—Procarbazine—brain cancer	0.000306	0.00268	CcSEcCtD
Formoterol—Palpitations—Temozolomide—brain cancer	0.000303	0.00266	CcSEcCtD
Formoterol—Myalgia—Carmustine—brain cancer	0.000302	0.00265	CcSEcCtD
Formoterol—Chest pain—Carmustine—brain cancer	0.000302	0.00265	CcSEcCtD
Formoterol—Anxiety—Carmustine—brain cancer	0.000301	0.00264	CcSEcCtD
Formoterol—Cough—Temozolomide—brain cancer	0.000299	0.00262	CcSEcCtD
Formoterol—Hypertension—Temozolomide—brain cancer	0.000296	0.0026	CcSEcCtD
Formoterol—Feeling abnormal—Hydroxyurea—brain cancer	0.000295	0.00259	CcSEcCtD
Formoterol—Vomiting—Procarbazine—brain cancer	0.000294	0.00258	CcSEcCtD
Formoterol—Cardiac disorder—Etoposide—brain cancer	0.000292	0.00256	CcSEcCtD
Formoterol—Arthralgia—Temozolomide—brain cancer	0.000292	0.00256	CcSEcCtD
Formoterol—Myalgia—Temozolomide—brain cancer	0.000292	0.00256	CcSEcCtD
Formoterol—Rash—Procarbazine—brain cancer	0.000292	0.00256	CcSEcCtD
Formoterol—Dermatitis—Procarbazine—brain cancer	0.000291	0.00256	CcSEcCtD
Formoterol—Anxiety—Temozolomide—brain cancer	0.000291	0.00255	CcSEcCtD
Formoterol—Headache—Procarbazine—brain cancer	0.00029	0.00254	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00029	0.00254	CcSEcCtD
Formoterol—Oedema—Carmustine—brain cancer	0.000289	0.00254	CcSEcCtD
Formoterol—Discomfort—Temozolomide—brain cancer	0.000288	0.00253	CcSEcCtD
Formoterol—Infection—Carmustine—brain cancer	0.000287	0.00252	CcSEcCtD
Formoterol—Dry mouth—Temozolomide—brain cancer	0.000285	0.0025	CcSEcCtD
Formoterol—Immune system disorder—Etoposide—brain cancer	0.000284	0.0025	CcSEcCtD
Formoterol—Mediastinal disorder—Etoposide—brain cancer	0.000284	0.00249	CcSEcCtD
Formoterol—Body temperature increased—Hydroxyurea—brain cancer	0.000283	0.00248	CcSEcCtD
Formoterol—Tachycardia—Carmustine—brain cancer	0.000282	0.00248	CcSEcCtD
Formoterol—Oedema—Temozolomide—brain cancer	0.00028	0.00245	CcSEcCtD
Formoterol—Anaphylactic shock—Temozolomide—brain cancer	0.00028	0.00245	CcSEcCtD
Formoterol—Infection—Temozolomide—brain cancer	0.000278	0.00244	CcSEcCtD
Formoterol—Nausea—Procarbazine—brain cancer	0.000275	0.00241	CcSEcCtD
Formoterol—Nervous system disorder—Temozolomide—brain cancer	0.000274	0.00241	CcSEcCtD
Formoterol—Skin disorder—Temozolomide—brain cancer	0.000272	0.00238	CcSEcCtD
Formoterol—Hypotension—Carmustine—brain cancer	0.00027	0.00237	CcSEcCtD
Formoterol—Dysgeusia—Etoposide—brain cancer	0.000268	0.00236	CcSEcCtD
Formoterol—Back pain—Etoposide—brain cancer	0.000265	0.00233	CcSEcCtD
Formoterol—Hypersensitivity—Hydroxyurea—brain cancer	0.000264	0.00231	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000264	0.00231	CcSEcCtD
Formoterol—Muscle spasms—Etoposide—brain cancer	0.000264	0.00231	CcSEcCtD
Formoterol—Insomnia—Carmustine—brain cancer	0.000262	0.0023	CcSEcCtD
Formoterol—Dyspnoea—Carmustine—brain cancer	0.000258	0.00226	CcSEcCtD
Formoterol—Somnolence—Carmustine—brain cancer	0.000257	0.00226	CcSEcCtD
Formoterol—Asthenia—Hydroxyurea—brain cancer	0.000257	0.00225	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000255	0.00224	CcSEcCtD
Formoterol—Ill-defined disorder—Etoposide—brain cancer	0.000254	0.00223	CcSEcCtD
Formoterol—Insomnia—Temozolomide—brain cancer	0.000253	0.00222	CcSEcCtD
Formoterol—Gastrointestinal disorder—Carmustine—brain cancer	0.00025	0.00219	CcSEcCtD
Formoterol—Dyspnoea—Temozolomide—brain cancer	0.000249	0.00219	CcSEcCtD
Formoterol—Somnolence—Temozolomide—brain cancer	0.000249	0.00218	CcSEcCtD
Formoterol—Constipation—Carmustine—brain cancer	0.000247	0.00217	CcSEcCtD
Formoterol—Pain—Carmustine—brain cancer	0.000247	0.00217	CcSEcCtD
Formoterol—Malaise—Etoposide—brain cancer	0.000247	0.00217	CcSEcCtD
Formoterol—Dyspepsia—Temozolomide—brain cancer	0.000246	0.00216	CcSEcCtD
Formoterol—Diarrhoea—Hydroxyurea—brain cancer	0.000245	0.00215	CcSEcCtD
Formoterol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000241	0.00212	CcSEcCtD
Formoterol—Fatigue—Temozolomide—brain cancer	0.000241	0.00212	CcSEcCtD
Formoterol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000241	0.0221	CbGpPWpGaD
Formoterol—Cough—Etoposide—brain cancer	0.000239	0.0021	CcSEcCtD
Formoterol—Constipation—Temozolomide—brain cancer	0.000239	0.0021	CcSEcCtD
Formoterol—Pain—Temozolomide—brain cancer	0.000239	0.0021	CcSEcCtD
Formoterol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000239	0.0219	CbGpPWpGaD
Formoterol—Feeling abnormal—Carmustine—brain cancer	0.000238	0.00209	CcSEcCtD
Formoterol—Hypertension—Etoposide—brain cancer	0.000237	0.00208	CcSEcCtD
Formoterol—Dizziness—Hydroxyurea—brain cancer	0.000237	0.00208	CcSEcCtD
Formoterol—Gastrointestinal pain—Carmustine—brain cancer	0.000237	0.00208	CcSEcCtD
Formoterol—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000236	0.0216	CbGpPWpGaD
Formoterol—Chest pain—Etoposide—brain cancer	0.000233	0.00205	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000232	0.00203	CcSEcCtD
Formoterol—Discomfort—Etoposide—brain cancer	0.000231	0.00202	CcSEcCtD
Formoterol—Feeling abnormal—Temozolomide—brain cancer	0.00023	0.00202	CcSEcCtD
Formoterol—Body temperature increased—Carmustine—brain cancer	0.000229	0.00201	CcSEcCtD
Formoterol—Abdominal pain—Carmustine—brain cancer	0.000229	0.00201	CcSEcCtD
Formoterol—Gastrointestinal pain—Temozolomide—brain cancer	0.000229	0.00201	CcSEcCtD
Formoterol—Vomiting—Hydroxyurea—brain cancer	0.000228	0.002	CcSEcCtD
Formoterol—Rash—Hydroxyurea—brain cancer	0.000226	0.00198	CcSEcCtD
Formoterol—Dermatitis—Hydroxyurea—brain cancer	0.000225	0.00198	CcSEcCtD
Formoterol—Headache—Hydroxyurea—brain cancer	0.000224	0.00197	CcSEcCtD
Formoterol—Anaphylactic shock—Etoposide—brain cancer	0.000224	0.00196	CcSEcCtD
Formoterol—Infection—Etoposide—brain cancer	0.000222	0.00195	CcSEcCtD
Formoterol—Urticaria—Temozolomide—brain cancer	0.000222	0.00195	CcSEcCtD
Formoterol—Body temperature increased—Temozolomide—brain cancer	0.000221	0.00194	CcSEcCtD
Formoterol—Abdominal pain—Temozolomide—brain cancer	0.000221	0.00194	CcSEcCtD
Formoterol—Tachycardia—Etoposide—brain cancer	0.000218	0.00192	CcSEcCtD
Formoterol—Skin disorder—Etoposide—brain cancer	0.000217	0.00191	CcSEcCtD
Formoterol—Hypersensitivity—Carmustine—brain cancer	0.000213	0.00187	CcSEcCtD
Formoterol—Nausea—Hydroxyurea—brain cancer	0.000213	0.00187	CcSEcCtD
Formoterol—Hypotension—Etoposide—brain cancer	0.000209	0.00183	CcSEcCtD
Formoterol—Asthenia—Carmustine—brain cancer	0.000208	0.00182	CcSEcCtD
Formoterol—Hypersensitivity—Temozolomide—brain cancer	0.000206	0.00181	CcSEcCtD
Formoterol—Asthenia—Temozolomide—brain cancer	0.000201	0.00176	CcSEcCtD
Formoterol—Dyspnoea—Etoposide—brain cancer	0.000199	0.00175	CcSEcCtD
Formoterol—Somnolence—Etoposide—brain cancer	0.000199	0.00175	CcSEcCtD
Formoterol—Diarrhoea—Carmustine—brain cancer	0.000198	0.00174	CcSEcCtD
Formoterol—Pruritus—Temozolomide—brain cancer	0.000198	0.00174	CcSEcCtD
Formoterol—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000194	0.0178	CbGpPWpGaD
Formoterol—Gastrointestinal disorder—Etoposide—brain cancer	0.000193	0.0017	CcSEcCtD
Formoterol—Fatigue—Etoposide—brain cancer	0.000193	0.00169	CcSEcCtD
Formoterol—Dizziness—Carmustine—brain cancer	0.000191	0.00168	CcSEcCtD
Formoterol—Pain—Etoposide—brain cancer	0.000191	0.00168	CcSEcCtD
Formoterol—Constipation—Etoposide—brain cancer	0.000191	0.00168	CcSEcCtD
Formoterol—Diarrhoea—Temozolomide—brain cancer	0.000191	0.00168	CcSEcCtD
Formoterol—Dizziness—Temozolomide—brain cancer	0.000185	0.00162	CcSEcCtD
Formoterol—Feeling abnormal—Etoposide—brain cancer	0.000184	0.00162	CcSEcCtD
Formoterol—Vomiting—Carmustine—brain cancer	0.000184	0.00161	CcSEcCtD
Formoterol—Gastrointestinal pain—Etoposide—brain cancer	0.000183	0.00161	CcSEcCtD
Formoterol—Rash—Carmustine—brain cancer	0.000182	0.0016	CcSEcCtD
Formoterol—Dermatitis—Carmustine—brain cancer	0.000182	0.0016	CcSEcCtD
Formoterol—Headache—Carmustine—brain cancer	0.000181	0.00159	CcSEcCtD
Formoterol—Vomiting—Temozolomide—brain cancer	0.000178	0.00156	CcSEcCtD
Formoterol—Urticaria—Etoposide—brain cancer	0.000178	0.00156	CcSEcCtD
Formoterol—Abdominal pain—Etoposide—brain cancer	0.000177	0.00155	CcSEcCtD
Formoterol—Body temperature increased—Etoposide—brain cancer	0.000177	0.00155	CcSEcCtD
Formoterol—Rash—Temozolomide—brain cancer	0.000176	0.00155	CcSEcCtD
Formoterol—Dermatitis—Temozolomide—brain cancer	0.000176	0.00155	CcSEcCtD
Formoterol—Headache—Temozolomide—brain cancer	0.000175	0.00154	CcSEcCtD
Formoterol—Nausea—Carmustine—brain cancer	0.000172	0.00151	CcSEcCtD
Formoterol—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000168	0.0155	CbGpPWpGaD
Formoterol—Nausea—Temozolomide—brain cancer	0.000166	0.00146	CcSEcCtD
Formoterol—Hypersensitivity—Etoposide—brain cancer	0.000165	0.00145	CcSEcCtD
Formoterol—Asthenia—Etoposide—brain cancer	0.000161	0.00141	CcSEcCtD
Formoterol—Pruritus—Etoposide—brain cancer	0.000158	0.00139	CcSEcCtD
Formoterol—Diarrhoea—Etoposide—brain cancer	0.000153	0.00134	CcSEcCtD
Formoterol—Dizziness—Etoposide—brain cancer	0.000148	0.0013	CcSEcCtD
Formoterol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000146	0.0134	CbGpPWpGaD
Formoterol—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000144	0.0132	CbGpPWpGaD
Formoterol—Vomiting—Etoposide—brain cancer	0.000142	0.00125	CcSEcCtD
Formoterol—Rash—Etoposide—brain cancer	0.000141	0.00124	CcSEcCtD
Formoterol—Dermatitis—Etoposide—brain cancer	0.000141	0.00124	CcSEcCtD
Formoterol—Headache—Etoposide—brain cancer	0.00014	0.00123	CcSEcCtD
Formoterol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.0123	CbGpPWpGaD
Formoterol—Nausea—Etoposide—brain cancer	0.000133	0.00117	CcSEcCtD
Formoterol—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000132	0.0121	CbGpPWpGaD
Formoterol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000118	0.0108	CbGpPWpGaD
Formoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000109	0.01	CbGpPWpGaD
Formoterol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.00997	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—SMO—brain cancer	0.000105	0.00964	CbGpPWpGaD
Formoterol—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000103	0.00944	CbGpPWpGaD
Formoterol—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.27e-05	0.00576	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—PTCH2—brain cancer	6.23e-05	0.00572	CbGpPWpGaD
Formoterol—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.18e-05	0.00568	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—PTCH2—brain cancer	6.09e-05	0.0056	CbGpPWpGaD
Formoterol—ADRB2—Arf6 signaling events—EGFR—brain cancer	5.87e-05	0.00539	CbGpPWpGaD
Formoterol—ADRB2—Arf6 trafficking events—CTNNB1—brain cancer	5.85e-05	0.00538	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.76e-05	0.0053	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.69e-05	0.00522	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—OR4C12—brain cancer	5.46e-05	0.00502	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—OR14C36—brain cancer	5.46e-05	0.00502	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—OR14C36—brain cancer	5.34e-05	0.00491	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—OR4C12—brain cancer	5.34e-05	0.00491	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—OR14C36—brain cancer	4.96e-05	0.00456	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—OR4C12—brain cancer	4.96e-05	0.00456	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—OR14C36—brain cancer	4.85e-05	0.00446	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—OR4C12—brain cancer	4.85e-05	0.00446	CbGpPWpGaD
Formoterol—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	4.61e-05	0.00424	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—SHH—brain cancer	3.21e-05	0.00295	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PTCH2—brain cancer	3.2e-05	0.00294	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—SHH—brain cancer	3.14e-05	0.00288	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PTCH2—brain cancer	3.13e-05	0.00287	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—PTCH1—brain cancer	3.04e-05	0.00279	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—SMO—brain cancer	3.04e-05	0.00279	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—PTCH1—brain cancer	2.98e-05	0.00273	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—SMO—brain cancer	2.98e-05	0.00273	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OR14C36—brain cancer	2.93e-05	0.00269	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OR4C12—brain cancer	2.93e-05	0.00269	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OR4C12—brain cancer	2.87e-05	0.00263	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OR14C36—brain cancer	2.87e-05	0.00263	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—ABR—brain cancer	2.76e-05	0.00254	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—ABR—brain cancer	2.7e-05	0.00248	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—ABR—brain cancer	2.51e-05	0.0023	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DTX2—brain cancer	2.49e-05	0.00229	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—ABR—brain cancer	2.45e-05	0.00225	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DTX2—brain cancer	2.44e-05	0.00224	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.41e-05	0.00221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTCH2—brain cancer	1.89e-05	0.00173	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTCH2—brain cancer	1.85e-05	0.0017	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HES5—brain cancer	1.83e-05	0.00168	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HES5—brain cancer	1.79e-05	0.00164	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STRADA—brain cancer	1.78e-05	0.00163	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.76e-05	0.00162	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP2C9—brain cancer	1.76e-05	0.00162	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	1.75e-05	0.00161	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STRADA—brain cancer	1.74e-05	0.0016	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—TRPC6—brain cancer	1.71e-05	0.00157	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—SHH—brain cancer	1.65e-05	0.00151	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—SHH—brain cancer	1.61e-05	0.00148	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.6e-05	0.00147	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—TRPC6—brain cancer	1.59e-05	0.00146	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—SMO—brain cancer	1.56e-05	0.00143	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PTCH1—brain cancer	1.56e-05	0.00143	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—TRPC6—brain cancer	1.55e-05	0.00143	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—SMO—brain cancer	1.53e-05	0.0014	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PTCH1—brain cancer	1.53e-05	0.0014	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—BSG—brain cancer	1.49e-05	0.00137	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ABR—brain cancer	1.48e-05	0.00136	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ABR—brain cancer	1.45e-05	0.00133	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GLI2—brain cancer	1.43e-05	0.00131	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GLI2—brain cancer	1.4e-05	0.00129	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GLI1—brain cancer	1.35e-05	0.00124	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GLI1—brain cancer	1.32e-05	0.00121	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—VAV1—brain cancer	1.31e-05	0.0012	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—IDH1—brain cancer	1.29e-05	0.00118	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—VAV1—brain cancer	1.28e-05	0.00118	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SUFU—brain cancer	1.28e-05	0.00117	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SUFU—brain cancer	1.25e-05	0.00115	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GFAP—brain cancer	1.23e-05	0.00113	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GFAP—brain cancer	1.2e-05	0.00111	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—VAV1—brain cancer	1.19e-05	0.00109	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HEY1—brain cancer	1.17e-05	0.00107	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—VAV1—brain cancer	1.16e-05	0.00107	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DLL1—brain cancer	1.14e-05	0.00105	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HEY1—brain cancer	1.14e-05	0.00105	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DLL1—brain cancer	1.12e-05	0.00103	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2C9—brain cancer	1.07e-05	0.000985	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ENO2—brain cancer	1.02e-05	0.000934	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2C9—brain cancer	9.86e-06	0.000906	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SHH—brain cancer	9.73e-06	0.000894	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SHH—brain cancer	9.51e-06	0.000874	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TRPC6—brain cancer	9.38e-06	0.000862	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SMO—brain cancer	9.22e-06	0.000847	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTCH1—brain cancer	9.22e-06	0.000847	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TRPC6—brain cancer	9.17e-06	0.000843	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BSG—brain cancer	9.11e-06	0.000837	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SMO—brain cancer	9.02e-06	0.000829	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTCH1—brain cancer	9.02e-06	0.000829	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BSG—brain cancer	8.38e-06	0.00077	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	8.32e-06	0.000764	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BSG—brain cancer	8.31e-06	0.000763	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	8.14e-06	0.000747	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—IDH1—brain cancer	7.84e-06	0.00072	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	7.55e-06	0.000694	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	7.39e-06	0.000679	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH2—brain cancer	7.37e-06	0.000677	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH2—brain cancer	7.21e-06	0.000662	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—IDH1—brain cancer	7.21e-06	0.000662	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—IDH1—brain cancer	7.15e-06	0.000657	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VAV1—brain cancer	7.03e-06	0.000646	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VAV1—brain cancer	6.87e-06	0.000632	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.38e-06	0.000586	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ENO2—brain cancer	6.19e-06	0.000569	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HES1—brain cancer	6.04e-06	0.000555	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HES1—brain cancer	5.91e-06	0.000543	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—IL2—brain cancer	5.85e-06	0.000538	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.82e-06	0.000535	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFRA—brain cancer	5.75e-06	0.000529	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—IL2—brain cancer	5.73e-06	0.000526	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ENO2—brain cancer	5.7e-06	0.000524	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ENO2—brain cancer	5.65e-06	0.000519	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFRA—brain cancer	5.63e-06	0.000517	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SPP1—brain cancer	5.59e-06	0.000513	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SPP1—brain cancer	5.46e-06	0.000502	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL2—brain cancer	5.31e-06	0.000488	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL2—brain cancer	5.2e-06	0.000478	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IRS2—brain cancer	5.05e-06	0.000464	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IRS2—brain cancer	4.94e-06	0.000454	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CG—brain cancer	4.66e-06	0.000428	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APC—brain cancer	4.46e-06	0.00041	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CG—brain cancer	4.46e-06	0.00041	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CG—brain cancer	4.36e-06	0.000401	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APC—brain cancer	4.36e-06	0.000401	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EGFR—brain cancer	4.06e-06	0.000373	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EGFR—brain cancer	3.98e-06	0.000365	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RELA—brain cancer	3.49e-06	0.00032	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ERBB2—brain cancer	3.46e-06	0.000318	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RELA—brain cancer	3.41e-06	0.000313	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ERBB2—brain cancer	3.39e-06	0.000311	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL2—brain cancer	3.14e-06	0.000288	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL2—brain cancer	3.07e-06	0.000282	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCND1—brain cancer	3.06e-06	0.000281	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CTNNB1—brain cancer	3.03e-06	0.000278	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCND1—brain cancer	2.99e-06	0.000275	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CTNNB1—brain cancer	2.96e-06	0.000272	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CG—brain cancer	2.84e-06	0.000261	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—brain cancer	2.67e-06	0.000245	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STAT3—brain cancer	2.64e-06	0.000243	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CG—brain cancer	2.61e-06	0.00024	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—brain cancer	2.61e-06	0.00024	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CG—brain cancer	2.59e-06	0.000238	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STAT3—brain cancer	2.58e-06	0.000237	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MYC—brain cancer	2.45e-06	0.000226	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MYC—brain cancer	2.4e-06	0.000221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGFR—brain cancer	2.4e-06	0.000221	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGFR—brain cancer	2.35e-06	0.000216	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TP53—brain cancer	2.02e-06	0.000185	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TP53—brain cancer	1.97e-06	0.000181	CbGpPWpGaD
